FDA Adds Warning to Seizure Drug
Philadelphia patients taking the anti-seizure drug Lamictal may want to see their doctor about a different medication. The Food and Drug Administration in conjunction with the manufacturer, GlaxoSmithKline, have decided to add a warning and re-label the medication after reports of aseptic meningitis.
Lamictal is prescribed to patients with a high risk of seizure and has also been approved by the FDA to treat patients suffering from manic depression. In an effort to warn patients of the potential serious side effect, GlaxoSmithKline will add language to the medication guide distributed to patients. In addition doctors and others in the health community will be advised of this rare but serious side effect.
Aseptic meningitis is a dangerous inflammation of the spinal cord and brain. Those diagnosed with aseptic meningitis experience headache, fever, chills and vomiting. Most suffers of aseptic meningitis must be hospital for the majority of the illness.
Related Sources:
FDA warns of brain problem with Glaxo seizure drug






